Are US flu death figures more PR than science?

Por Doshi, Peter
Publicado em 2005

Influenza vaccination: policy versus evidence: Policy is in the lead

Por Doshi, Peter
Publicado em 2006

Reason for optimism

Por Doshi, Peter
Publicado em 2008

Trends in Recorded Influenza Mortality: United States, 1900–2004

Por Doshi, Peter
Publicado em 2008

Popular and Scientific Attitudes Regarding Pandemic Influenza

Por Doshi, Peter
Publicado em 2008

DOSHI RESPONDS

Por Doshi, Peter
Publicado em 2008

The elusive definition of pandemic influenza

Por Doshi, Peter
Publicado em 2011

Clinical study reports of randomised controlled trials: an exploratory review of previously confidential industry reports

Por Doshi, Peter, Jefferson, Tom
Publicado em 2013

North American regulatory agencies can and should make clinical trial data publicly available

Por Persaud, Nav, Doshi, Peter
Publicado no CMAJ (2016)

Open data 5 years on: a case series of 12 freedom of information requests for regulatory data to the European Medicines Agency

Por Doshi, Peter, Jefferson, Tom
Publicado no Trials (2016)

The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience

Por Doshi, Peter, Jefferson, Tom, Del Mar, Chris
Publicado em 2012

Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis

Por Jefferson, Tom, Jones, Mark, Doshi, Peter, Del Mar, Chris
Publicado em 2009

Restoring invisible and abandoned trials: a call for people to publish the findings

Por Doshi, Peter, Dickersin, Kay, Healy, David, Vedula, S Swaroop, Jefferson, Tom
Publicado em 2013

Influenza vaccination of health care workers

Por Doshi, Peter, Abi-Jaoude, Elia, Lexchin, Joel, Jefferson, Tom, Thomas, Roger E.
Publicado em 2013

Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments

Por Jefferson, Tom, Jones, Mark, Doshi, Peter, Spencer, Elizabeth A, Onakpoya, Igho, Heneghan, Carl J
Publicado em 2014

Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies

Por Spelsberg, Angela, Prugger, Christof, Doshi, Peter, Ostrowski, Kerstin, Witte, Thomas, Hüsgen, Dieter, Keil, Ulrich
Publicado no BMJ (2017)

Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011

Por Doshi, Peter, Hur, Peter, Jones, Mark, Albarmawi, Husam, Jefferson, Tom, Morgan, Daniel J., Spears, Patricia A., Powers, John H.
Publicado no JAMA Intern Med (2017)

Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports

Por Jefferson, Tom, Jones, Mark A, Doshi, Peter, Del Mar, Chris B, Hama, Rokuro, Thompson, Matthew J, Onakpoya, Igho, Heneghan, Carl J
Publicado em 2014

Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data.

Por Heneghan, Carl J, Onakpoya, Igho, Jones, Mark A, Doshi, Peter, Del Mar, Chris B, Hama, Rokuro, Thompson, Matthew J, Spencer, Elizabeth A, Mahtani, Kamal R, Nunan, David, Howick, Jeremy, Jefferson, Tom
Publicado no Health Technol Assess (2016)

Integrating multiple data sources (MUDS) for meta-analysis to improve patient-centered outcomes research: a protocol for a systematic review

Por Mayo-Wilson, Evan, Hutfless, Susan, Li, Tianjing, Gresham, Gillian, Fusco, Nicole, Ehmsen, Jeffrey, Heyward, James, Vedula, Swaroop, Lock, Diana, Haythornthwaite, Jennifer, Payne, Jennifer L., Cowley, Theresa, Tolbert, Elizabeth, Rosman, Lori, Twose, Claire, Stuart, Elizabeth A., Hong, Hwanhee, Doshi, Peter, Suarez-Cuervo, Catalina, Singh, Sonal, Dickersin, Kay
Publicado no Syst Rev (2015)